Richard Malamut has been appointed chief medical officer of Collegium Pharmaceutical (NASDAQ: [[ticker:COLL]]). He joins the Stoughton, MA, company from Braeburn Pharmaceuticals, where he was chief medical officer, head of research and development, and senior vice president. Malamut’s experience also includes posts at Avanir Pharmaceuticals and Teva Pharmaceutical (NYSE: [[ticker:TEVA]]). Collegium develops and sells pain management drugs.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
